Emmanuelle Charpentier Max Planck Unit for the Science of Pathogens, Germany
Prof. Emmanuelle Charpentier is a world-renowned French microbiologist and Nobel Laureate, currently serving as Director at the Max Planck Unit for the Science of Pathogens in Germany. She is best known for co-developing the revolutionary CRISPR-Cas9 gene-editing technology, which has transformed genetic engineering and biomedical research. Her groundbreaking discovery enables precise, efficient, and cost-effective modification of DNA, opening new possibilities in gene therapy, disease modeling, and biotechnology. In recognition of this pioneering work, she was awarded the Nobel Prize in Chemistry in 2020, shared with Jennifer Doudna. Prof. Charpentier’s research focuses on molecular mechanisms of infection and the regulation of gene expression in pathogens. She has made significant contributions to understanding bacterial immunity and RNA biology. With a high global citation impact, she is among the most influential scientists in life sciences. She has received numerous prestigious awards, including the Breakthrough Prize and the Kavli Prize. Her work continues to drive innovation in genome engineering and precision medicine. Prof. Charpentier remains a leading figure shaping the future of genetic and biomedical research.
